UW Medicine Banner UW Medicine Home Page UW Department of Obstetrics and Gynecology Home Page
Support our Mission:
Make a
Tax-Deductible
Donation
Take me to:
Mission Statement  
Clinical Services
Patient Education
Faculty
Divisions
Research
Professional Education
Calendar & News
Links & Resources
Ob/Gyn Dept Home  
Ob/Gyn Department
Division of Gynecologic Oncology
Heidi J Gray, MD

Heidi J Gray, MD
Assistant Professor

University of Washington
Department of Obstetrics & Gynecology
Box 356460
Seattle, WA 98195-6460

  Main | Affiliations | Publications

Academic Office:
Clinic Appts:
(206) 543-3669
(206) 288-2273 (new patients)
(206) 288-6200 (returning patients)
Specialties:
Gynecologic Oncology:
• Complex gynecologic oncology surgery
• Treatment of gynecologic cancers
• Clinical trials for gynecologic cancers
• Immunotherapy for gynecologic malignancies
Licensure:
• Washington, 1999
Certification:

• Obstetrics and Gynecology, 2005
• Gynecologic Oncology, 2007

Joined UW Medicine: 7/16/04
Education:

• MD degree
   (University of California, Los Angeles, 1997)
• Residency in Obstetrics and Gynecology
   (University of Washington, 2001)
• Fellowship in Gynecologic Oncology
   (Hospital of University of Pennsylvania, 2004)

Research 
Interests:
• Immunotherapy for gynecologic malignancies
• Clinical trials
Current 
Research:

Identification of an Immunologic Signature of Ovarian Cancer for Use as
  an Early Cancer Screen

Professional 
Organizations:

• American College of Obstetricians and Gynecologists
• Gynecologic Oncology Group
• Puget Sound Oncology Consortium
• Society of Gynecologic Oncologists
• Western Association of Gynecologic Oncologists

Selected 
Publications:

Greer BE, Swensen RE, Gray HJ. Surgery for ovarian cancer: rationale and guidelines. JNCCN. in press.

Fox KV, Shah CA, Swisher EM, Garcia RL, Mandel LS, Gray HJ, Swensen RE, Goff BA. An evaluation of cervical cancer in women age sixty and over. Gynecol Oncol. 2008;109(1):53-8.

Shah CA, Allison KH, Garcia RL, Gray HJ, Goff BA, Swisher EM. Intratumoral T cells, tumor associated macrophages, and regulatory T cells: association with p53 mutations, circulating tumor DNA and survival in women with ovarian cancer. Gynecol Oncol. 2008 May;109(2):215-9.

Gray HJ. Primary management of early stage cervical cancer (IA1-1B) and appropriate selection of adjuvant therapy. J Natl Compr Canc Netw. 2008;6(1):47-52.

Galic V, Willner J, Wollan M, Garg R, Garcia R, Goff BA, Gray HJ, Swisher E. Common polymorphisms in TP53 and MDM2 and the relationship to TP53 mutations and clinical outcomes in women with ovarian and peritoneal carcinomas. Genes Chromosomes Cancer. 2007;46(3):239-47.

Garg R, Wollan M, Galic V, Garcia R, Goff BA, Gray HJ, Swisher E. Common polymorphism in interleukin 6 influences survival of women with ovarian and peritoneal carcinoma. Gynecol Oncol. 2006;103(3):793-6.

Goodell V, Salazar L, Urban N, Drescher CW, Gray HJ, Swensen RE, McIntosh MW, Disis ML. Antibody immunity to oncogenic proteins is a prognostic indicator in ovarian cancer. J Clinic Oncol. 2006;24(5):762-8.

Dardarian TS, Gray HJ, Morgan MA, Rubin SC, Randall TC. Saphenous vein sparing during inguinal lymphadenectomy to reduce morbidity in patients with vulvar carcinoma. Gynecol Oncol. 2006;101(1):140-2.

Kim SH, Srinivas SK, Rubin SC, Freedman LJ, Gray HJ. Delayed hemorrhage following cervical conization due to severe Factor IX deficiency. Obstet Gynecol. 2004;104(5):1189-92.


Home | Mission Statement | Clinical Services | Patient Education | Faculty | Divisions | Research | Professional Education | Calendar & News | Links
Copyright © 2009 University of Washington
Please report problems to Webmaster.UW.ObGyn [at] (Webmaster)
spacer